Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Social Influence on Pain
NCT03060031Phase 1Completed
- Sponsor
- University of Colorado Boulder
- Start
- Jun 2017
- Primary completion
- Mar 2019
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of oxytocin nasal spray in pain (2 arms), sponsored by University of Colorado Boulder. Primary endpoints: Change in pain expectation rating score, Change in pain rating score and 1 more. Started Jun 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT03060031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03060031.